Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Rising healthcare costs not directly tied to medical technology, according to study
A recent study by European researchers casts doubt on widespread claims that medical technology is the key driver of rising healthcare expenditures.
Read more
2. Boston Scientific launches U.S. Parkinson’s trial, cites interim EU data
Boston Scientific launches a U.S. clinical trial of its Vercise deep-brain stimulation treatment for Parkinson’s disease and touts interim data from a European trial of the device.
1. St. Jude’s Durata defibrillator ‘immune’ to Riata flaws?
St. Jude Medical’s Durata implantable cardiac defibrillator leads should be "relatively immune" to the problems that led to a recall for the medical device company’s Riata ICD leads, according to a cardiologist who helped bring the Riata problems to light.
